 | Landos Biopharma, Inc. | |||
| NCM : LABP || Location: United States | ||||
$22.4-0.09 (-0.4%) |
0.01 M | 22.4 - 22.55 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 0.001 M |
| March 28, 2024 | 0.005 M |
| March 15, 2024 | 0.001 M |
| Feb. 29, 2024 | 0.001 M |
| Feb. 15, 2024 | 0.004 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.93 | -0.99 | -6.08% |
| 09/30/2023 | -0.90 | -0.94 | -4.13% |
| 06/30/2023 | -1.12 | -0.63 | 43.85% |
| 03/31/2023 | -0.97 | -0.90 | 7.12% |
| 12/31/2022 | -1.94 | -1.30 | 32.92% |
LABP Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 3.119M | Shares Float | 1.321M |
| Short Float | 0.001M | Market Cap | 70.15M |
| Institution ownership | 50.52% | Insider ownership | 9.909% |
| Earnings Date | 05/10/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -3.50 | Forward EPS | -1.68 |